Gen-Probe to Add Real-Time PCR Capability to Next-Gen Panther MDx Platform | GenomeWeb

By Ben Butkus

Gen-Probe is in the early stages of developing a new version of its Panther molecular diagnostics system that will include real-time PCR capabilities on top of the platform's current isothermal amplification technology.

The company said that the new system, which is expected to be launched in 2015, will serve as a platform for real-time PCR-based assays developed through Prodesse, which Gen-Probe acquired in October 2009.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.